share_log

民生证券股份有限公司关于安旭生物2023年年度报告信息披露监管问询函回复的核查意见

Minsheng Securities Co., Ltd.'s verification opinion on An Xu Biotech's 2023 Annual Report Information Disclosure Regulatory Inquiry Letter

Sensex a share ·  May 27

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.